Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center ...

We look for passionate and high-calibre candidates to join our team.

Explore Novartis

Featured / Mar 12

Coronavirus disease (COVID-19) update

Novartis is monitoring the coronavirus situation with safety of associates and patients globally our primary concern. We are also responding to an industry-wide research and development appeal and have made a global commitment on the price of generic medicines.

Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics.